Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

Global Market Today: Asian stocks rise after tech-led rebound in US

Asian markets opened higher today. Technology shares led the gains, boosting Wall Street. This rally eased worries about artificial intellig...